Einar Bjornsson

Summary

Affiliation: Sahlgrenska University Hospital
Country: Sweden

Publications

  1. ncbi Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 41:1464-72. 2006
  2. ncbi Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Liver Int 30:251-8. 2010
  3. ncbi [Acute liver failure--rapid multidisciplinary management]
    Einar Bjornsson
    Medicinkliniken, Gastrosektionen, Sahlgrenska Universitetssjukhuset, Goteborg
    Lakartidningen 104:210-3. 2007
  4. ncbi Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature
    Einar Bjornsson
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    Hepatology 45:1547-54. 2007
  5. ncbi The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury
    E Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Aliment Pharmacol Ther 25:1411-21. 2007
  6. ncbi Long-term follow-up of patients with mild to moderate drug-induced liver injury
    E Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Aliment Pharmacol Ther 26:79-85. 2007
  7. ncbi Non-alcoholic fatty liver disease
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 42:1023-30. 2007
  8. ncbi The clinical aspects of non-alcoholic fatty liver disease
    E Bjornsson
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Minerva Gastroenterol Dietol 54:7-18. 2008
  9. ncbi Hepatotoxicity associated with antiepileptic drugs
    E Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Acta Neurol Scand 118:281-90. 2008
  10. ncbi The natural history of small-duct primary sclerosing cholangitis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Gastroenterology 134:975-80. 2008

Detail Information

Publications62

  1. ncbi Gastrointestinal symptoms in patients with liver cirrhosis: associations with nutritional status and health-related quality of life
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 41:1464-72. 2006
    ..Our aim was to prospectively evaluate gastrointestinal symptoms, malnutrition, and QoL in patients with cirrhosis...
  2. ncbi Fatigue measurements in patients with primary biliary cirrhosis and the risk of mortality during follow-up
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Liver Int 30:251-8. 2010
    ..Fatigue was recently suggested to predict an increased risk of mortality in a primary biliary cirrhosis (PBC) cohort during follow-up...
  3. ncbi [Acute liver failure--rapid multidisciplinary management]
    Einar Bjornsson
    Medicinkliniken, Gastrosektionen, Sahlgrenska Universitetssjukhuset, Goteborg
    Lakartidningen 104:210-3. 2007
  4. ncbi Immunoglobulin G4 associated cholangitis: description of an emerging clinical entity based on review of the literature
    Einar Bjornsson
    Department of Internal Medicine, Division of Gastroenterology and Hepatology, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    Hepatology 45:1547-54. 2007
  5. ncbi The impact of eosinophilia and hepatic necrosis on prognosis in patients with drug-induced liver injury
    E Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Aliment Pharmacol Ther 25:1411-21. 2007
    ..Drug-induced liver injury may be immunologically mediated or metabolically induced. Peripheral eosinophilia and liver eosinophilia in suspected drug-induced liver injury generally supports the role of drug aetiology...
  6. ncbi Long-term follow-up of patients with mild to moderate drug-induced liver injury
    E Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Aliment Pharmacol Ther 26:79-85. 2007
    ..To evaluate the long-term prognosis of patients diagnosed with drug-induced liver injury, and the nature of the liver injury...
  7. ncbi Non-alcoholic fatty liver disease
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 42:1023-30. 2007
  8. ncbi The clinical aspects of non-alcoholic fatty liver disease
    E Bjornsson
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Minerva Gastroenterol Dietol 54:7-18. 2008
    ..Some pharmacological pilot trials have been undertaken in NAFLD, but no proved treatment for all patients with NAFLD and/or NASH is available at the current time...
  9. ncbi Hepatotoxicity associated with antiepileptic drugs
    E Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Acta Neurol Scand 118:281-90. 2008
    ..Early referral of patients with severe liver reactions and coagulopathy to liver transplant centers before encephalopathy can be the difference between liver transplantation and death...
  10. ncbi The natural history of small-duct primary sclerosing cholangitis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Gastroenterology 134:975-80. 2008
    ..We aimed at determining the natural history and long-term outcomes of a large number of patients with small-duct PSC...
  11. ncbi Immunoglobulin G4-associated cholangitis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Curr Opin Gastroenterol 24:389-94. 2008
    ..This review is focused mainly on the most recent studies published during the last 2 years that have increased our understanding of this clinical entity...
  12. ncbi Fate of patients with obstructive jaundice
    Einar Bjornsson
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    J Hosp Med 3:117-23. 2008
    ..Systematic data are limited on the etiology and prognosis of unselected patients with obstructive jaundice (OJ). We aimed to review the clinical features, etiology, and prognosis of patients with OJ...
  13. ncbi The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    J Hepatol 50:511-7. 2009
    ..Chronic evolution after drug-induced liver injury (DILI) has been reported. How often this leads to liver-related morbidity and mortality is unexplored...
  14. ncbi Small-duct primary sclerosing cholangitis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Med Pol II, SE 413 45 Gothenburg, Sweden
    Curr Gastroenterol Rep 11:37-41. 2009
    ..Recurrence of small-duct PSC after liver transplantation has been reported. Cholangiocarcinoma, the most feared complication of PSC, has not been described in a patient with small-duct PSC without progression first to large-duct PSC...
  15. ncbi Management of primary sclerosing cholangitis
    E Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Minerva Gastroenterol Dietol 55:163-72. 2009
    ..No curative therapy for PSC is available at the current time except liver transplantation. The etiopathogenesis of PSC is unknown but the underlying pathophysiology of PSC is beyond the scope of this paper...
  16. ncbi Health-related quality of life in patients with different stages of liver disease induced by hepatitis C
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 44:878-87. 2009
    ..The aim of this study was to determine HRQoL in patients in different stages of hepatitis C virus (HCV) and to compare HRQoL in HCV cirrhosis with non-HCV-induced cirrhosis...
  17. ncbi The natural history of drug-induced liver injury
    Einar Bjornsson
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Semin Liver Dis 29:357-63. 2009
    ..Recent studies have shown that DILI can infrequently evolve into chronic liver injury including cirrhosis and even liver-related morbidity and mortality in a minority of patients...
  18. ncbi Discontinuation of proton pump inhibitors in patients on long-term therapy: a double-blind, placebo-controlled trial
    E Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Aliment Pharmacol Ther 24:945-54. 2006
    ..The proportion of proton pump inhibitor users on long-term therapy who can discontinue proton pump inhibitor (PPI) medication without developing symptoms is unknown...
  19. ncbi Clinical characteristics and prognostic markers in disulfiram-induced liver injury
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    J Hepatol 44:791-7. 2006
    ..Limited systematic data exists on the incidence of drug-induced hepatotoxicity due to disulfiram and the most important prognostic markers. We aimed to determine the nature and frequency of suspected disulfiram hepatotoxicity in Sweden...
  20. ncbi Long-term follow-up of patients with alcoholic liver disease after liver transplantation in Sweden: impact of structured management on recidivism
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, SE 413 45 Gothenburg, Sweden
    Scand J Gastroenterol 40:206-16. 2005
    ..Data are limited on the impact of structured management of the alcohol problem on the risk of recidivism following transplantation in ALD...
  21. ncbi Fatigue is not a specific symptom in patients with primary biliary cirrhosis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg Sweden
    Eur J Gastroenterol Hepatol 17:351-7. 2005
    ..Limited data exist on comparison with fatigue in the general population and comparison with patients with other chronic gastrointestinal disorders are lacking...
  22. ncbi [Interpretation of liver tests is decisive for the choice of examination in hepatocellular jaundice]
    Einar Bjornsson
    Medicinkliniken, Gastrosektionen, Sahlgrenska Universitetssjukhuset, Goteborg
    Lakartidningen 102:2154-7. 2005
    ..It is concluded that specialized units should investigate patients with jaundice and a medical gastroenterologist should be contacted early in the hospitalization of these patients...
  23. ncbi Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 40:1095-101. 2005
    ..The aim of this study was to determine the nature and number of suspected adverse drug-induced liver disease associated with fatalities and/or liver transplantation since reporting of adverse drug reactions (ADRs) started in Sweden...
  24. ncbi Intestinal permeability and bacterial growth of the small bowel in patients with primary sclerosing cholangitis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 40:1090-4. 2005
    ..Small-bowel intestinal permeability was assessed as the differential urinary excretion of lactulose/L-rhamnose...
  25. ncbi Fatigue in patients with primary sclerosing cholangitis
    E Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 39:961-8. 2004
    ..The occurrence of fatigue in primary sclerosing cholangitis (PSC), its impact on quality of life and the role of concomitant inflammatory bowel disease (IBD) and coexisting irritable bowel syndrome (IBS) is unexplored...
  26. ncbi Effects of duodenal lipids on gastric sensitivity and relaxation in patients with ulcer-like and dysmotility-like dyspepsia
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Digestion 67:209-17. 2003
    ..Our aim was to elucidate the differences in gastric sensorimotor function in these subgroups of FD. 13 healthy controls (HC) and 20 patients with FD, 10 ULD and 10 DLD, were included...
  27. ncbi Severe jaundice in Sweden in the new millennium: causes, investigations, treatment and prognosis
    E Bjornsson
    Dept of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 38:86-94. 2003
    ....
  28. ncbi Patients with small duct primary sclerosing cholangitis have a favourable long term prognosis
    E Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Gut 51:731-5. 2002
    ..Patients with cholestatic liver function tests and histological features of primary sclerosing cholangitis (PSC) but a normal cholangiogram are considered to have small duct PSC. The natural history of this condition is unknown...
  29. ncbi Drug-induced liver injury: Hy's rule revisited
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Clin Pharmacol Ther 79:521-8. 2006
  30. ncbi Suspected drug-induced liver fatalities reported to the WHO database
    E Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Med Pol II, SE 413 45 Gothenburg, Sweden
    Dig Liver Dis 38:33-8. 2006
    ..World Health Organisation drug monitoring started in 1968. No systematic investigation has been carried out using this database of adverse drug reactions with liver injury associated with fatalities...
  31. ncbi Increased risk for malignant neoplasms among patients with cirrhosis
    Evangelos Kalaitzakis
    Institute of Internal Medicine, University of Gothenburg, Sahlgrenska Academy, Gothenburg, Sweden
    Clin Gastroenterol Hepatol 9:168-74. 2011
    ..It is not clear how cirrhosis affects the risks for hepatocellular carcinoma (HCC) and non-HCC cancers, which are rare among these patients. We assessed the risk for malignant neoplasms in patients with cirrhosis...
  32. ncbi High prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis
    Rolf Olsson
    Department of Medicine, Sahlgrenska University Hospital Sahlgrenska, Goteborg, Sweden
    Eur J Intern Med 20:190-6. 2009
    ..We describe a high prevalence of small duct primary sclerosing cholangitis among patients with overlapping autoimmune hepatitis and primary sclerosing cholangitis...
  33. ncbi Factors related to fatigue in patients with cirrhosis before and after liver transplantation
    Evangelos Kalaitzakis
    Institute of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Clin Gastroenterol Hepatol 10:174-81, 181.e1. 2012
    ..We performed a prospective study to evaluate fatigue and identify potential determinants among patients with cirrhosis. We also studied the effects of liver transplantation on fatigue in these patients...
  34. ncbi Primary sclerosing cholangitis associated with elevated immunoglobulin G4: clinical characteristics and response to therapy
    Einar Bjornsson
    Division of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Am J Ther 18:198-205. 2011
    ..Most patients had a good biochemical response to steroids, but adverse effects were common. Future work should be directed at finding therapy that is more effective, better tolerated, and of more lasting benefit...
  35. ncbi Autoimmune hepatitis-PBC overlap syndrome: a simplified scoring system may assist in the diagnosis
    Matthias Neuhauser
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota, USA
    Am J Gastroenterol 105:345-53. 2010
    ..Furthermore, we sought to compare the outcome in PBC patients with and without the features of AIH overlap...
  36. ncbi Long-term follow-up of patients with acute liver failure of indeterminate aetiology
    Gu Wei
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 43:984-91. 2008
    ....
  37. ncbi Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    BMC Gastroenterol 8:46. 2008
    ..We aimed to determine the impact of cirrhosis etiology on hepatic encephalopathy and whether hepatic encephalopathy affects health-related QoL among patients with cirrhosis of different etiologies...
  38. ncbi Prevalence of gastrointestinal symptoms in patients with chronic obstructive pulmonary disease
    Anna Niklasson
    Department of Internal Medicine, Sahlgrenska University Hospital, Goteborg, Sweden
    Eur J Gastroenterol Hepatol 20:335-41. 2008
    ....
  39. ncbi Role of gastric sensorimotor dysfunction in gastrointestinal symptoms and energy intake in liver cirrhosis
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 42:237-46. 2007
    ..The aim of this study was to investigate gastric accommodation to a meal and sensitivity to gastric distension with reference to energy intake, nutritional status and gastrointestinal symptoms in liver cirrhosis...
  40. ncbi Malnutrition and diabetes mellitus are related to hepatic encephalopathy in patients with liver cirrhosis
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Liver Int 27:1194-201. 2007
    ..Our aim was to investigate the effects of malnutrition and diabetes mellitus on HE in unselected patients with liver cirrhosis...
  41. ncbi Factors that reduce health-related quality of life in patients with primary sclerosing cholangitis
    Maria Benito de Valle
    Institute of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Clin Gastroenterol Hepatol 10:769-775.e2. 2012
    ..We aimed to evaluate HRQL and its potential determinants in 2 population-based cohorts of patients with PSC and to study the prevalence of fatigue among these patients...
  42. ncbi Drug-induced autoimmune hepatitis: clinical characteristics and prognosis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Landspitali University Hospital, Reykjavik, Iceland
    Hepatology 51:2040-8. 2010
    ..These two groups have similar clinical and histological patterns. However, DIAIH patients do not seem to require long-term immunosuppressive therapy...
  43. ncbi Outcome and prognostic markers in severe drug-induced liver disease
    Einar Bjornsson
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, SE 413 45 Gothenburg, Sweden
    Hepatology 42:481-9. 2005
    ..In conclusion, hepatocellular jaundice has a high but variable mortality rate, depending on the drug involved. The AST and bilirubin levels are the most important predictors of death or liver transplantation...
  44. ncbi The relationship between symptoms, body mass index, gastrointestinal transit and stool frequency in patients with irritable bowel syndrome
    Riadh Sadik
    Department of Internal Medicine, Sahlgrenska University Hospital, Göteborg 41345, Sweden
    Eur J Gastroenterol Hepatol 22:102-8. 2010
    ..The aim of this prospective study was to characterize the relationships between symptoms in IBS, GI transit, as a measure of GI motility, and BMI...
  45. ncbi Dyspeptic symptom development after discontinuation of a proton pump inhibitor: a double-blind placebo-controlled trial
    Anna Niklasson
    Department of Internal Medicine, Section of Gastroenterology, Sahlgrenska University Hospital, Richertsgatan 18, Göteborg 412 60, Sweden
    Am J Gastroenterol 105:1531-7. 2010
    ..Conflicting data exist on whether discontinuation of proton pump inhibitors (PPIs) is associated with rebound secretion of gastric acid...
  46. ncbi Intestinal permeability in cirrhotic patients with and without ascites
    Evangelos Kalaitzakis
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 41:326-30. 2006
    ..The aim of this study was to assess whether intestinal permeability is altered in cirrhotic patients with and without ascites...
  47. ncbi Dominant strictures in patients with primary sclerosing cholangitis
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University, Gothenburg, Sweden
    Am J Gastroenterol 99:502-8. 2004
    ..We aimed to determine the prevalence of DS in patients with PSC and the spontaneous course of ALP and bilirubin, up to a year from diagnosis in patients with and without DS...
  48. ncbi Inadequate use of proton-pump inhibitors in patients with liver cirrhosis
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Eur J Gastroenterol Hepatol 20:512-8. 2008
    ..Patients with liver cirrhosis have a high prevalence of gastrointestinal symptoms. The use of antiacid therapy (AAT) in these patients is unexplored. We aimed to assess the use of AAT in cirrhotic patients...
  49. ncbi Gut transit is associated with gastrointestinal symptoms and gut hormone profile in patients with cirrhosis
    Evangelos Kalaitzakis
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Clin Gastroenterol Hepatol 7:346-52. 2009
    ....
  50. ncbi Impact of peri-transplant heart failure & left-ventricular diastolic dysfunction on outcomes following liver transplantation
    Axel Josefsson
    Institute of Internal Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Liver Int 32:1262-9. 2012
    ..Assess the prevalence of peri-transplant heart failure and its potential relation to post-transplant morbidity and mortality...
  51. ncbi Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials
    Perjohan Lindfors
    Department of Internal Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Am J Gastroenterol 107:276-85. 2012
    ..The objective of this study was to study the effect of gut-directed hypnotherapy in IBS in different clinical settings outside the traditional research units...
  52. ncbi Coronary artery disease in patients with liver cirrhosis
    Evangelos Kalaitzakis
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, 413 45 Gothenburg, Sweden
    Dig Dis Sci 55:467-75. 2010
    ..We aimed to determine the prevalence and predictive factors of CAD in a cohort of consecutive patients with cirrhosis of various etiologies compared to the general population...
  53. ncbi Altered postprandial glucose, insulin, leptin, and ghrelin in liver cirrhosis: correlations with energy intake and resting energy expenditure
    Evangelos Kalaitzakis
    Department of Internal Medicine, Faculty of Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Am J Clin Nutr 85:808-15. 2007
    ..Liver cirrhosis is associated with reduced energy intake and increased resting energy expenditure...
  54. ncbi Incidence and prevalence of primary sclerosing cholangitis in a defined adult population in Sweden
    Bjorn Lindkvist
    Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    Hepatology 52:571-7. 2010
    ..The prevalence of PSC at the end of the study period is the highest reported to date. This implies that the medical burden of PSC may be higher than estimated previously...
  55. ncbi Liver cirrhosis in Iceland and Sweden: incidence, aetiology and outcomes
    Steingerdur Anna Gunnarsdottir
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 44:984-93. 2009
    ..The incidence and mortality of liver cirrhosis in Iceland has been reported to be the lowest in the Western world. There are very few data on aetiology, incidence and prognosis among cirrhotics in Sweden...
  56. ncbi Pharmacokinetic study of esomeprazole in patients with hepatic impairment
    Henrik Sjovall
    Sahlgrenska University Hospital, Goteborg, Sweden
    Eur J Gastroenterol Hepatol 14:491-6. 2002
    ..To evaluate the pharmacokinetics and safety of esomeprazole (Nexium), the S-isomer of omeprazole, after repeated oral dosing in patients with hepatic impairment...
  57. ncbi Renal function and cognitive impairment in patients with liver cirrhosis
    Evangelos Kalaitzakis
    Section of Gastroenterology and Hepatology, Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Scand J Gastroenterol 42:1238-44. 2007
    ..Renal function has been shown to be important for ammonia metabolism in cirrhosis. Although renal dysfunction is common in cirrhotic patients, its effect on cognitive function is largely unexplored...
  58. ncbi The AST/ALT ratio as an indicator of cirrhosis in patients with PBC
    Helena Nyblom
    Department of Internal Medicine, Sahlgrenska University Hospital, , , Sweden
    Liver Int 26:840-5. 2006
    ..In a multivariate analysis, bilirubin and ALP were predictors of poor prognosis. CONCLUSION: The AST/ALT ratio seems to be of clinical value as a hint to the diagnosis of cirrhosis in patients with PBC but not as a prognostic factor...
  59. ncbi Hepatotoxicity associated with statins: reports of idiosyncratic liver injury post-marketing
    Einar Bjornsson
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, The National University Hospital, Reykjavik, Iceland
    J Hepatol 56:374-80. 2012
    ..Limited data exist on drug-induced liver injury (DILI) associated with statins...
  60. ncbi [Helicobacter pylori can in rare cases be the cause of iron and vitamin B 12 deficiency. No increased risk of iron and vitamin B 12 deficiency due to proton pump inhibitors]
    Niklas Mattsson
    Sahlgrenska Universitetssjukhuset, Goteborg
    Lakartidningen 101:2014-5. 2004
    ..The safety of long-term use of PPI is well documented, but it is still unclear whether PPI accelerates the development of atrophic corpus gastritis in the presence of H pylori...
  61. ncbi A review of esomeprazole in the treatment of gastroesophageal reflux disease (GERD)
    Evangelos Kalaitzakis
    Department of Internal Medicine, Section of Gastroenterology and Hepatology, Sahlgrenska University Hospital Gothenburg, Sweden
    Ther Clin Risk Manag 3:653-63. 2007
    ....
  62. ncbi Abstinence in patients with alcoholic liver cirrhosis: A follow-up study
    Evangelos Kalaitzakis
    Department of Internal Medicine, Sahlgrenska University Hospital, Gothenburg, Sweden
    Hepatol Res 38:869-76. 2008
    ..Cirrhosis severity (expressed as the MELD) and alcohol abuse treatment during follow up were related to short-term mortality...